• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

NPJ Biofilms Microbiomes . The resident gut microbiome modulates the effect of synbiotics on the immunogenicity after SARS-COV-2 vaccination in eld

tetano

Editor, Senior Moderator
NPJ Biofilms Microbiomes


. 2025 Aug 25;11(1):171.
doi: 10.1038/s41522-025-00804-9. The resident gut microbiome modulates the effect of synbiotics on the immunogenicity after SARS-COV-2 vaccination in elderly and diabetes patients

Lin Zhang[SUP] #[/SUP][SUP] 1 2 3 4 [/SUP], Shilan Wang[SUP] #[/SUP][SUP] 1 3 4 [/SUP], Martin C S Wong[SUP] 5 6 [/SUP], Chris K P Mok[SUP] 5 7 8 [/SUP], Jessica Y L Ching[SUP] 1 9 [/SUP], Joyce W Y Mak[SUP] 9 [/SUP], Chunke Chen[SUP] 7 [/SUP], Bing Huo[SUP] 1 [/SUP], Shuai Yan[SUP] 1 3 4 [/SUP], Chun Pan Cheung[SUP] 1 9 [/SUP], Emily O L Chiu[SUP] 1 9 [/SUP], Emily Y T Fung[SUP] 1 9 [/SUP], Pui Kuan Cheong[SUP] 1 9 [/SUP], Francis K L Chan[SUP] 10 11 12 13 [/SUP], Siew C Ng[SUP] 14 15 16 17 [/SUP]



Affiliations
Abstract

The study aims to tackle the seed and soil microbiome and mechanisms that contribute to the effect of synbiotics in enhancing immunogenicity after SARS-CoV-2 vaccination in elderly and diabetic patients. Among 369 subjects who received 3 months of SIM01, a gut microbiota-derived synbiotic formula of three Bifidobacterium strains (B. adolescentis, B. bididum, and B. longum) or a placebo after the SARS-CoV-2 vaccines (mRNA vaccine BNT162b2 (Pfizer-BioNTech) or the inactivated vaccine Sinovac-CoronaVac), we performed metagenomic sequencing in stool samples of 280 vaccinees collected at baseline and 3-month postvaccination and metabonomic sequencing in 276 vaccinees collected at baseline and 1-month postvaccination. The open niche of autochthonous gut microbiota (lower levels of Bifidobacterium and decreased functional potential for carbohydrate metabolism) was associated with enhancing SIM01-contained species. The enrichment of three bifidobacterial species after 3 months of SIM01 intervention (BABBBL_fc) was positively correlated with the level of neutralizing antibodies to the BNT162b2 vaccine at 6-month postvaccination. The fold change of benzoic acid was positively correlated with BABBBL_fc in the BNT162b2 vaccinees, which was also implicated with SARS-CoV-2 surrogate virus neutralization test (sVNT)% levels at 1-month postvaccination. Importantly, SIM01 strain engraftment assessed by StrainPhlAn (A metagenomic strain-level population genomics tool) was associated with a higher fold change of three bifidobacterial species and could be predicted based on the baseline gut microbiome. Therefore, the resident gut microbiome affected the SIM01 engraftment, which was associated with the immunogenicity of SARS-CoV-2 BNT162b2 vaccines.


 
Back
Top Bottom